PYPD NASDAQ
PolyPid Ltd.
1W: -0.6%
1M: -2.1%
3M: -7.0%
YTD: +19.3%
1Y: +54.0%
3Y: -37.1%
5Y: -97.9%
$5.19
-0.18 (-3.35%)
Weekly Expected Move ±5.8%
$5
$5
$5
$5
$6
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$99.0M
52W Range3.06-5.73
Volume167,717
Avg Volume185,176
Beta1.42
Dividend—
Analyst Ratings
Company Info
CEODikla Czaczkes Akselbrad
Employees72
SectorHealthcare
IndustryBiotechnology
IPO Date2020-06-26
Websitepolypid.com
18 Hasivim Street
Petah Tikva, HM 4959376
IL
Petah Tikva, HM 4959376
IL
972 7 4719 5700
About PolyPid Ltd.
PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions. These solutions are based on its proprietary polymer-lipid encapsulation matrix (PLEX) platform, with the goal of addressing significant unmet medical needs. The company's leading product candidate, D-PLEX100, is currently undergoing Phase III clinical trials. It is being evaluated for its efficacy in preventing surgical site infections (SSIs) following both sternal (bone) and abdominal (soft tissue) procedures. Established in 2008, PolyPid Ltd. is headquartered in Petah Tikva, Israel.
Latest News
European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀
PolyPid Regains European Commercialization Rights for D-PLEX₁₀₀, Expanding Global Commercialization Opportunities
PolyPid Announces Participation in Upcoming Fall Investor Conferences
PolyPid (PYPD) Q2 2026 Earnings Call Transcript
PolyPid Ltd. Q2 2026 Earnings Call Summary
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Barenholz Yechezkel | A-Award | 9,132 | $4.46 | 2026-07-15 |
| Stein Robert Benjami | A-Award | 9,132 | $4.46 | 2026-07-15 |
| Dror-Darwish Nir | A-Award | 9,132 | $4.46 | 2026-07-15 |
| BenAmram Joseph | A-Award | 9,132 | $4.46 | 2026-07-15 |
| Krinsky Itzhak | A-Award | 9,132 | $4.46 | 2026-07-15 |